Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 200,000 shares.
January 30, 2024 at 01:41 pm IST
Share
Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:A011040) announces a share repurchase program. Under the program, the company will repurchase up to 200,000 shares, pursuant to a contract with Samsung Securities Co., Ltd. The purpose of the program is to enhance shareholder value through stabilizing stock prices. The program will expire on April 29, 2024.
As of January 29, 2024, the company had 3,626,996 shares in treasury within scope available for dividend and had no shares in treasury under other capacities.
KYUNG DONG PHARMACEUTICAL CO.,LTD. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Companyâs products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. It also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.
KYUNG DONG PHARMACEUTICAL CO., LTD. 
